Related by context. All words. (Click for frequent words.) 68 rheumatologists 67 Gastroenterologists 66 Endocrinologists 64 Overactive Bladder 64 Oncologists 63 topical NSAIDs 62 surveyed rheumatologists 62 GnRH agonists 62 antiarrhythmic drug 62 GERD sufferers 62 urinary incontinence UI 62 Nephrologists 62 fibromyalgia syndrome 62 Urologists 62 endoscopists 62 MYCAMINE 62 PCPs 61 venlafaxine Effexor 61 Nesiritide 61 aromatase inhibitors AIs 61 Adverse Event 61 podiatric physicians 60 Benign Prostatic Hyperplasia BPH 60 Afib 60 antiepileptics 60 stable angina 60 Rheumatoid Arthritis Patients 60 oral anticoagulants 60 Prescribers 60 Generalized Anxiety Disorder 60 Platelet Inhibition 60 #F FDG PET 60 Bronchial Thermoplasty 60 ARIXTRA R 60 ENTs 60 antiplatelet medications 59 MedPredict 59 lipid lowering agents 59 surveyed PCPs 59 EBUS FNA 59 ACTEMRA TM 59 Anticoagulants 59 Treated Patients 59 overactive bladder symptoms 59 aldosterone antagonist 59 clevidipine 59 CAM therapies 59 KRAS status 59 aldosterone antagonists 59 Heart Failure Patients 59 refractive surgeons 59 carotid stents 59 Lupus Nephritis 59 AMEVIVE 59 NCCN guidelines 59 Interventional Cardiologists 59 Diabetic Retinopathy 59 Chronic Heart Failure 59 Severe Asthma 59 infliximab Remicade 59 Urodynamics 59 Atypical antipsychotics 59 vasomotor symptoms 59 colon capsule endoscopy 58 antiplatelet agents 58 REMINYL ® 58 LYSTEDA 58 pharmacotherapies 58 quinolone 58 pregabalin Lyrica 58 INVEGA ® 58 MRgFUS 58 Breast Surgeons 58 poor metabolizers 58 Detrol Detrol LA 58 Rheumatoid Arthritis RA 58 VTE prophylaxis 58 Rhinitis 58 neuroradiologists 58 Adalimumab 58 Demonstrates Efficacy 58 Milnacipran 58 Spinal Manipulation 58 Pivotal Clinical Trial 58 INVEGA ® SUSTENNA ® 58 Pemphigus 58 CIMZIA ™ 58 Acute Coronary Syndromes 58 Irritable Bowel Syndrome IBS 58 physician assistants PAs 58 BARI 2D 58 macrolide antibiotics 58 antihypertensive therapy 58 Cardiovascular Outcomes 58 hepatologists 58 ZACTIMA 58 retinal specialists 58 NeuroStar TMS Therapy 58 Inflammatory Bowel Diseases 58 pharmacologic treatments 58 ACE Inhibitors 58 Ischemic Stroke 58 Asclera 58 PRADAXA 58 androgen deficiency 58 abacavir Ziagen 58 null responder 58 PsA 58 COREG 58 solifenacin 58 Zestra R 58 biologic DMARDs 58 Ranolazine 58 eCME 57 Warfarin Coumadin 57 ablation procedures 57 Subgroup analyzes 57 GI motility disorders 57 Contraindications 57 NATRECOR ® 57 TMP SMX 57 Schizophrenia Treatment 57 NOMID 57 Venous Thromboembolism 57 Dabigatran 57 BENICAR HCT 57 Capsule Endoscopy 57 agomelatine 57 atherosclerotic renal artery stenosis 57 leukotriene receptor antagonists 57 INFERGEN 57 Maple Leaf HIFU 57 Catheterization 57 AVERROES 57 Neuropathic Pain 57 leukotriene receptor antagonist 57 heterozygous FH 57 ß blockers 57 Renal Cell Carcinoma RCC 57 RISPERDAL ® 57 Patient Outcomes 57 Nonsurgical 57 antithrombotic therapy 57 MTWA testing 57 Antiplatelet 57 nociceptive pain 57 rheumatic diseases 57 COPAXONE R 57 β blockers 57 valvular heart 57 Improved Survival 57 superficial bladder cancer 57 podiatric physician 57 HoLEP 57 Acute Heart Failure 57 RE LY trial 57 chronic prostatitis 57 Chronic Sinusitis 57 AA Amyloidosis 57 Metastatic Prostate Cancer 57 TMJ disorders 57 Heart Transplant Recipients 57 Traficet EN 57 psoriasis sufferers 57 pharmacogenetic testing 57 Guideline Update 57 neratinib 57 phase IIIb 57 Diabetic Patients 57 ZOLINZA 57 antihypertensive drugs 57 lipid lowering medications 57 Chronic Constipation 57 dosage regimens 57 Perforomist ™ Inhalation Solution 57 ARIXTRA 57 sertraline Zoloft 57 Uterine Fibroids 57 Corticosteroids 57 adalimumab Humira 57 aspirin clopidogrel 57 VADT 57 certolizumab 57 DVT PE 57 UCB Cimzia 57 Angioedema 57 Doxil ® 57 Velcade bortezomib 57 TMS Therapy 57 multicenter trials 57 Fracture Risk 57 Surgical Procedures 57 AFib 56 APTIVUS r 56 symptomatic fibroids 56 Bergenstal 56 PROactive study 56 Bifantis 56 atypical Hemolytic Uremic Syndrome 56 ticagrelor Brilinta 56 sunitinib malate 56 BioTrends 56 glitazones 56 Arrhythmias 56 EchoCRT 56 LLLT 56 Diabetic Neuropathy 56 treating uterine fibroids 56 STRIDE PD 56 Clinicians 56 Anesthesiologists ASA 56 TYKERB 56 pharmacoeconomic 56 ganetespib 56 EVISTA 56 Cognitive Impairment 56 penicillin allergy 56 thromboprophylaxis 56 antihypertensive medications 56 Pulmonary Arterial Hypertension 56 PROCRIT R 56 VerifyNow System 56 DNAwithPap TM Test 56 OAB symptoms 56 Elitek 56 atrasentan 56 KRN# 56 relapsed MM 56 hypertensive patients 56 rFVIIa 56 receiving VELCADE 56 brivaracetam 56 GW# [003] 56 PROLARIS 56 ritonavir boosted 56 BOXED WARNING 56 juvenile idiopathic arthritis 56 anticlotting drugs 56 neuropsychiatric symptoms 56 constipation OIC 56 Vertex telaprevir 56 Clinical Trial Data 56 cerebral microbleeds 56 STELARA TM 56 Juvenile Idiopathic Arthritis 56 CONCERTA 56 Cardiometabolic 56 MAGE A3 ASCI 56 topical retinoid 56 intracranial stenosis 56 Glatiramer Acetate 56 ruboxistaurin 56 Healthcare Professionals 56 Combination Treatment 56 hyaluronic acid dermal fillers 56 overactive bladder OAB 56 polyarticular 56 ixabepilone 56 Patient Registry 56 intravitreal injections 56 thetreatment 56 Fabry Disease 56 Shows Efficacy 56 Digital Mammographic Imaging 56 Eye MDs 56 Allergists 56 Restless Legs Syndrome RLS 56 adalimumab 56 Efudex 56 SilverHawk Plaque Excision System 56 BRCA testing 56 Aldara Cream 56 Bivalirudin 56 Myelodysplastic Syndromes 56 Epiduo 56 Internists 56 sorafenib Nexavar 56 Chronic Migraine 56 Fluconazole 56 lipid lowering medication 56 ORENCIA ® 56 biologic therapy 56 osteopathic manipulative treatment 56 See CLINICAL PHARMACOLOGY 56 myelodysplastic myeloproliferative diseases 56 antiplatelet therapies 56 antimuscarinic 56 pediatric rheumatologists 56 Nilotinib 56 INTEGRILIN R 56 dermatologic surgeons 56 NATRECOR R 56 KETEK 56 tumor histology 56 nasal allergy symptoms 56 Hepatotoxicity 56 Kidney Transplant Patients 56 citalopram Celexa 56 gefitinib Iressa 56 invasive candidiasis 56 rhinosinusitis 56 HCV Protease Inhibitor 56 Coronary Artery Bypass Graft 56 enzastaurin 56 rheumatologic 56 Respiratory Disorders 56 gonococcal infections 56 CYPHER Stent 56 ST Segment Elevation 55 stratifying patients 55 trials RCTs 55 trastuzumab Herceptin ® 55 antimicrobial prophylaxis 55 overactive bladder syndrome 55 Fibrates 55 bone scintigraphy 55 Spirus Medical 55 Prostatitis 55 HORIZONS AMI 55 Arimidex anastrozole 55 INVEGA ™ 55 Potiga 55 Venous thromboembolism 55 Survival Benefit 55 dopamine partial agonist 55 Hepatocellular Carcinoma HCC 55 prognostic markers 55 Naive Patients 55 AVANDIA 55 Beta Blockers 55 HCPs 55 Clinical Trial Results 55 carotid stenosis 55 randomized multicenter trial 55 Ketotransdel TM 55 teriflunomide 55 Obstructive Sleep Apnea 55 NAVISTAR R 55 Hemodialysis Patients 55 Focalin XR 55 anticoagulant warfarin 55 vidofludimus 55 WARNINGS Myopathy Rhabdomyolysis 55 prelicensure 55 Cardiotoxicity 55 Pemetrexed 55 Patients Receiving 55 tolterodine ER 55 Chronic Myelogenous Leukemia 55 Pivotal Trial 55 ACCORD Lipid 55 carotid artery stenting CAS 55 clinicians 55 placebo controlled clinical trials 55 myofascial pain syndrome 55 Natalizumab 55 Anticoagulation 55 migraineurs 55 transcatheter aortic valve implantation 55 pan HDAC inhibitor 55 OSAHS 55 KRAS mutation 55 INVEGA 55 efalizumab 55 Acute Myocardial Infarction AMI 55 HER2 overexpression 55 RhuDex 55 surveyed gastroenterologists 55 Clinical Practice Guidelines 55 DPNP 55 Juvenile Idiopathic Arthritis JIA 55 Aggrastat ® tirofiban hydrochloride 55 riociguat 55 nurse practitioners NPs 55 patients undergoing CABG 55 DEXILANT 55 Patients Treated With 55 renal artery stenosis 55 Dr. Atcha 55 Neoadjuvant Chemotherapy 55 CRH O'Regan System 55 AF ablation procedures 55 Parnate 55 pyridostigmine 55 anticoagulation clinics 55 VerifyNow 55 prodromal symptoms 55 ALCL 55 Prostate Cancer Patients 55 vismodegib 55 nephrologists 55 pharmacologic therapies 55 Stress Incontinence 55 Atypical Antipsychotics 55 osteoarthritis rheumatoid arthritis 55 Elderly Patients 55 SYNTAX 55 chronic myocardial ischemia 55 Systemic Sclerosis 55 Ralivia TM 55 acid suppressing 55 antiepileptic drug 55 Combo Therapy 55 liver transplant recipients 55 transrectal ultrasound guided 55 Endarterectomy 55 Catheter Ablation 55 SCIg 55 Disease Modification 55 Temsirolimus 55 MACUGEN 55 Vertebroplasty 55 Beta Blocker 55 HIV HCV coinfected 55 oral anticoagulation 55 AVELOX 55 Mestinon 55 Biologics Compendium 55 ImmuKnow assay 55 randomized controlled trials RCTs 55 BoNTA 55 oral antidiabetic medication 55 malignant pleural mesothelioma 55 intensive statin therapy 55 Screening Trial DMIST 55 LUTS 55 Interstitial Cystitis 55 renal tumors 55 antiplatelet drugs 55 invasive aspergillosis 55 Nasal Sprays 55 Pertuzumab 55 Pediatric Patients 55 Clinical Practice Guideline 55 Triptan 55 Tiotropium 55 SEDASYS ® System 55 placebo controlled trials 55 MIRAPEX 55 Drug Eluting Stents 55 Antitumor Activity 55 Paroxysmal Nocturnal Hemoglobinuria PNH 55 Electronic Brachytherapy 55 Colorectal Screening 55 ALK inhibitors 55 epidural steroid injection 55 Dysmenorrhea 55 Blepharospasm 55 empiric treatment 55 narcolepsy cataplexy 55 nonmelanoma skin cancers 55 ACUITY trial 55 PGx 55 Interventional Procedures 55 Advanced Melanoma 55 Severe Sepsis 55 Invasive Breast Cancer 55 Kyphon Balloon Kyphoplasty 55 forodesine 55 Adjunctive 55 pulmonologists 55 antibiotic prophylaxis 55 ACS NSQIP 55 renal denervation 54 Osteoarthritis Patients 54 Myelodysplastic Syndrome MDS 54 Pooled Analysis 54 Neurostimulation 54 Chronic HCV 54 Cinacalcet 54 Etanercept 54 Minimally Invasive Procedure 54 physicians 54 postoperative atrial fibrillation 54 psoriatic arthritis PsA 54 topical corticosteroids 54 Sexual Dysfunction 54 Medication Adherence 54 Epoetin Alfa 54 Abciximab 54 Randomized trials 54 tipranavir ritonavir 54 mycophenolate mofetil 54 Sinus Dynamics 54 clozapine Clozaril 54 palifermin 54 Osteoporosis Drugs 54 Aflibercept 54 HCV SPRINT 54 PFO closure 54 metastatic renal cell carcinoma 54 Nocturia 54 Diabetic Nephropathy 54 symptomatic carotid stenosis 54 Major Depressive Disorder 54 Estrogen Therapy 54 pain palliation 54 ROCKET AF 54 galiximab 54 thyroid nodules 54 antithrombotic therapies 54 antiplatelet medication 54 PREZISTA r 54 systemic lupus erythematosus SLE 54 colorectal liver metastases 54 anti angiogenic therapy 54 Instanyl 54 Pharmacoeconomic 54 Postmenopausal Women 54 INVEGA R 54 ADAGIO study 54 Full Prescribing Information 54 diagnostic modality 54 Inflammatory Markers 54 Ob Gyns 54 anticholinergic medications 54 Medication Errors 54 Triptans 54 immunosuppressant therapy 54 decitabine 54 Pulmonologists 54 RoACTEMRA 54 RRMS patients 54 coexisting illnesses 54 APTIVUS ritonavir 54 prospective multicentre 54 bevacizumab Avastin 54 duplex ultrasonography 54 DEFINITY ® 54 nondrug treatments 54 STEP BD 54 oncologists 54 Dendreon Provenge 54 adjunctively 54 Renal Artery 54 TGFBR1 * 6A 54 Alemtuzumab 54 neoadjuvant treatment 54 inhaled bronchodilators 54 AFRS TM 54 gastrointestinal stromal tumors GIST 54 warfarin dosing 54 Knee Osteoarthritis 54 PROCRIT ® 54 oxycodone CR 54 solid organ transplantation 54 erythropoietin stimulating agents 54 Polypharmacy 54 gynecologic oncologists 54 differentiated thyroid 54 nephron sparing surgery 54 Topical Gel 54 EUS FNA 54 dopaminergic therapy 54 PrandiMet 54 neurologists 54 Blinatumomab 54 Interventional radiology 54 olanzapine LAI 54 UA NSTEMI 54 Dasatinib 54 Phase III Trials 54 LUMINATE 54 Medifacts 54 IBS C 54 Celgene Revlimid 54 concomitant medications 54 interventional therapies 54 Cilostazol 54 Investigational Treatment 54 Meets Primary Endpoint 54 Thiazolidinediones 54 ONTARGET 54 intravenous bisphosphonates 54 vWD 54 perioperatively 54 inhaled corticosteroid therapy 54 nicardipine 54 Acthar Gel 54 angiographic outcomes 54 Minimally Invasive Treatment 54 recurrent GBM 54 Clinical Relevance 54 Zarnestra 54 Adefovir 54 IRESSA 54 tocilizumab 54 anticholinergic agents 54 Dialysis Outcomes 54 BEXXAR Therapeutic Regimen 54 Pharmacotherapy 54 AZILECT 54 Peyronie 54 PRoFESS 54 ASMBS 54 Asthma COPD 54 KAPIDEX 54 olaparib 54 tipranavir 54 prospective longitudinal 54 Plaque Psoriasis 54 Cardiologists 54 Treatment Resistant 54 Stenting Trial CREST 54 REVEAL Registry 54 tasocitinib 54 hemodialysis patients 54 anticoagulation therapy 54 hypochondriasis 54 Colorectal Cancer Patients 54 sleep apneas 54 Certican 54 Pfizer Lyrica 54 Clinical Efficacy 54 RCTs 54 Hematologists 54 NCCN Drugs & 54 KRAS variant 54 RE LY 54 Dyslipidemia 54 Metabolic Endocrinology 54 randomized Phase IIb 54 Lung Transplantation 54 bronchial thermoplasty 54 Coronary CTA 54 Transplant Rejection 54 atypical femur fractures 54 Migraine sufferers 54 osteoporotic compression fractures 54 Patients Treated 54 Enlarged Prostate 54 CLINICAL PHARMACOLOGY 54 Anesthetists 54 BRAF inhibitor 54 NCCN Guidelines ™ 54 Akten TM 54 rheumatic disorders 54 Kamada AAT 54 triptans 54 Watchful Waiting 54 patientswith 54 evaluating REVLIMID 54 heparin induced thrombocytopenia 54 reflux symptoms 54 immunomodulatory therapy 54 Lubiprostone 54 Lamictal XR 54 thrombolytic agents 54 QOPI 54 allergen avoidance 54 Autoimmune Diseases 54 ATACAND 54 comorbid conditions 54 Genasense ® 54 YONDELIS 54 HER2 Positive Breast Cancer 54 Inflammatory Diseases 54 ICAAC IDSA 54 urogynecologists 54 Cholesterol Levels SPARCL 54 Patients Undergoing 54 HuMax EGFr 54 thrombolytic therapy 54 monovision 54 Cotavance 54 urinary symptoms 54 Resistant Hypertension 54 newer antipsychotics 54 levosimendan 54 alvimopan 54 atherothrombosis 54 Surgical Mesh 54 Investigational Agent 54 Allovectin 7 ® 54 Chronic Fatigue Syndrome CFS 54 antiangiogenic agents 54 femoral neck fractures 54 Orthostatic Hypotension 54 LymphoStat B 54 psychopharmacological 53 Breast Cancer Recurrence 53 coinfected patients 53 anti angiogenic agents 53 Referenced EEG 53 diabetic neuropathic pain 53 Pelvic Organ Prolapse 53 Atypical Hemolytic Uremic Syndrome 53 Lung Cancer Patients 53 chronic migraine sufferers 53 guideline concordant 53 EoE 53 PANVAC VF 53 BARACLUDE ® 53 intravesical therapy 53 Ocrelizumab 53 retrospective cohort 53 FOLPI 53 Carotid Endarterectomy 53 paclitaxel eluting stents 53 therapeutic regimens 53 Renal Function 53 labetalol 53 cytoreductive surgery 53 Peginterferon 53 immunochemical fecal occult 53 prospective nonrandomized 53 Inflammatory diseases 53 ENGAGE AF TIMI 53 postoperative radiotherapy 53 Infected Patients 53 Adenomas 53 eltrombopag 53 Improves Survival 53 Cristofanilli 53 Solid Tumors 53 non ulcer dyspepsia 53 DRX# ™ 53 oral antidiabetes drugs 53 HQK 53 Pliaglis TM 53 REMICADE ® 53 orthostatic hypotension 53 Oral Fingolimod 53 CHANTIX 53 Aortic Dissection 53 Neurologists 53 miRview ™ mets 53 CIMZIA TM certolizumab pegol 53 Advanced Renal Cell 53 PTNS 53 Ceflatonin 53 CLBP 53 Jackevicius 53 antiangiogenic therapy 53 LHON 53 recurrent glioma 53 IOP lowering 53 Cutaneous T 53 assn.org 53 Reduced Risk 53 SIR Spheres 53 Sipuleucel T 53 sinusitis sufferers 53 QTinno 53 Pixuvri 53 VFEND 53 radioimmunotherapy RIT 53 electrophysiologists 53 RX Acculink 53 resynchronization therapy 53 Tumor Response 53 Zemplar Capsules 53 histological subtype 53 NIASPAN 53 efavirenz EFV 53 relapsing MS 53 immunocompromised patients 53 Angioplasties 53 Evaluation WISE 53 Clinical Guideline 53 Avandia Actos 53 noscapine 53 proliferative diabetic retinopathy 53 ASBMR 53 Survival Rates 53 placebo controlled clinical 53 Hsp# Inhibitor 53 tibolone 53 SJIA 53 serologic testing 53 preclinically 53 AAAAI 53 nonadherence 53 PROSTVAC TM 53 RECIST Response Evaluation Criteria 53 underdiagnosis 53 non squamous NSCLC 53 Ozurdex 53 Erlotinib 53 treat enlarged prostate 53 FDG-PET/CT 53 Irritable Bowel 53 Tesmilifene 53 thrombophilia 53 evaluating tivozanib 53 prescribe statins 53 revascularization procedures 53 pentoxifylline 53 Interventional Radiology interventional radiologisiceberg lettuces 53 Neoadjuvant 53 Systemic Lupus Erythematosus SLE 53 ACR# ACR# 53 Cystoscopy 53 ZOMIG R 53 Newly Diagnosed Patients 53 renal dietitians 53 CP CPPS 53 rEEG 53 PLAC test 53 Dialysis Patients 53 Recurrences 53 Package Insert 53 symptomatic BPH 53 relapsed SCLC 53 Dr. Durrie 53 anticholinergics 53 Treatment Shows Promise 53 Pfizer Revatio 53 HIFU therapy 53 NearVision CK 53 Diabetes Hypertension 53 lipid lowering drugs 53 Analgesic 53 benign prostatic hypertrophy BPH 53 Spondylitis 53 Bipolar Disorders 53 antiplatelet 53 FFR measurements 53 allogeneic HSCT 53 degenerative spondylolisthesis 53 prospective multicenter study 53 oral bisphosphonates 53 episodic migraine 53 Colposcopy 53 chronic LBP 53 Photodynamic Therapy 53 atypicals 53 reflux disease 53 Diagnostic Criteria 53 Acute Myocardial Infarction 53 Dermatologic 53 Intervention Effectiveness 53 testosterone supplementation 53 gynecologic procedures 53 CR# vcMMAE 53 Ambrisentan 53 Decitabine 53 moderate renal impairment 53 Alternative Treatments 53 acid reducer 53 systolic hypertension 53 orthopaedists 53 elevated CRP 53 Serious Adverse Events 53 exemestane Aromasin 53 surgeons radiologists 53 Hematologic 53 cediranib 53 Echocardiography 53 protease inhibitor PI 53 Bipolar Depression 53 dose statin therapy 53 endoscopic examinations 53 Breast Cancer Treatment 53 pertuzumab 53 Rheumatoid 53 ENDEAVOR IV 53 peginterferon alfa 53 HPA axis suppression 53 Skin Lesions 53 endometrial hyperplasia 53 prostate TURP 53 phakic intraocular lenses 53 Female Stress Urinary 53 randomizing patients 53 statin cholesterol lowering 53 monoamine oxidase inhibitors 53 Estybon ™ 53 InterStim Therapy 53 Coumadin warfarin 53 QTc prolongation 53 painful diabetic neuropathy 53 Androgen Deprivation Therapy 53 Nephrology Neurology 53 Virtual Colonoscopy 53 comorbid depression 53 PICSO ® 53 Hand ASSH 53 nonfasting triglyceride levels 53 ACTOplus met 53 Hyphanox 53 SYNTAX trial 53 Rheumatology ACR 53 urothelial carcinoma 53 Chronic Hepatitis B 53 Maven Semantic 53 multicenter clinical 53 prostate cancer CaP 53 COR Analyzer 53 Uterine Fibroid 53 MoxDuo TM IR 53 Prostate Biopsy 53 Bronchiectasis 53 Aggressive Reduction 53 macrovascular disease 53 Anti Clotting Drug 53 Randomized Comparison 53 Society ILADS 53 carotid artery stenting 53 Solesta 53 Percutaneous Coronary Intervention 53 USGI Medical 53 Amrubicin 53 XIENCE 53 neuropathies 53 GBA mutations 53 nonsurgical treatments 53 Physician Finder 53 clinico pathological 53 INSPIRE Trial Phase III 53 gynaecologic 53 antireflux surgery 53 trabectedin 53 Statin Therapy 53 MitraClip device 53 FinESS 53 Lilly Cymbalta 53 clinically meaningful improvements 53 chemoembolization 53 MERLIN TIMI 53 Practice Patterns 53 Phase IIIb clinical 53 Meta analyzes 53 corticosteroid creams 53 CYPHER ® 53 carotid endarterectomy CEA 53 Postmenopausal 53 ALTTO 53 nasal obstruction 53 Brain Metastases 53 FDA Approvals 53 CCX# 53 oral FTY# 53 Thrombolysis 53 Dr. Grekos 53 Rhinosinusitis 53 Multiple Myeloma Patients 53 AstraZeneca Toprol XL 53 Carfilzomib 53 ImmuKnow 53 SYNERGY Stent 53 SGAs 53 Confocal Microscopy 53 Microplasmin 53 Pazopanib 53 refractory metastatic 53 invasive coronary angiography 53 arthralgias 52 patients 52 PinPointe FootLaser 52 subgroup analyzes 52 anti angiogenic drugs 52 levodopa therapy 52 PROSTVAC ® 52 nonmelanoma skin cancer 52 phase IIb study 52 Xelox 52 Fibromyalgia Syndrome FMS 52 Carotid Revascularization Endarterectomy vs. 52 incidentalomas 52 Myocardial Ischemia 52 Peripheral Vascular Disease 52 CALGB 52 BSGI MBI 52 Fibromyalgia Syndrome 52 ACAAI 52 undergoing peritoneal dialysis 52 Contact Lens Wearers 52 Fingolimod 52 pregabalin 52 lupus nephritis 52 Botox Botox Cosmetic 52 palliative radiotherapy 52 EECP R 52 PD2i ® 52 AneuRx 52 urothelial cancer 52 Screening Trial 52 rt PA 52 REYATAZ ® 52 tricyclic antidepressant 52 diagnostic angiography 52 follicular lymphomas 52 Migraineurs 52 Ixempra 52 rizatriptan 52 endoscopist 52 tapentadol ER 52 warfarin therapy 52 Heterozygous Familial Hypercholesterolemia 52 Newly Diagnosed Multiple Myeloma 52 #-# Full Text 52 gastroenterological 52 ThermoDox R 52 CABG surgeries 52 Peripheral Arterial Disease 52 ICD implantation 52 spontaneous regression 52 PegIntron